viewOpen Orphan PLC

Open Orphan: New deal with top-three pharma company is 'evidence validation is building'

Proactive Research analyst Emma Ulker says the news this morning that Open Orphan PLC (LON:ORPH) subsidiary hVIVO has signed a £4mln contract with an unnamed top-three global pharma company is evidence that the validation is building as well as recognition amongst larger players in the industry. The respiratory syncytial virus (RSV) trial will take place at hVIVO’s London quarantine unit and is expected to be completed by the end of the first quarter next year.

Quick facts: Open Orphan PLC

Price: 24.25 GBX

AIM:ORPH

Market: AIM

Market Cap: £161.98 m

Follow

View company profile

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Open Orphan PLC - Open Orphan 'period of integration, restructuring and setting the scene' for future growth

Analyst interview

Open Orphan first half: 'period of integration, restructuring and setting the scene' for future growth

Analyst interview

Open Orphan: New deal with top-three pharma company is 'evidence validation is building'

on 10/8/20

Analyst interview

Open Orphan PLC targeting Q3 for profitability as it expands range of pharma and COVID-19 services

on 25/6/20

Analyst interview

Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'

on 14/5/20

More on this story

Open Orphan PLC - Open Orphan 'period of integration, restructuring and setting the scene' for future growth

Open Orphan first half: 'period of integration, restructuring and...

on 30/9/20

Open Orphan PLC -

Open Orphan PLC targeting Q3 for profitability as it expands range...

on 25/6/20

Open Orphan PLC - Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'

Open Orphan PLC: 'Rapidly scaling up and building out higher...

on 14/5/20

Venn Life Sciences holds just over a quarter of new AIM listing...

on 5/4/17

Watch

Open Orphan PLC - Open Orphan 'period of integration, restructuring and setting the scene' for future growth

Open Orphan first half: 'period of integration, restructuring and setting...

Proactive Analyst Emma Ulker talks through how Open Orphan (LON:ORPH) performed in the first half of the year. In the six-month period to June 2020, the company focused on integration and restructuring following its acquisition of lab services and challenge studies specialist hVIVO in...

on 30/9/20

Open Orphan PLC -

Health Open Orphan PLC targeting Q3 for profitability as it expands range...

on 25/6/20

Open Orphan PLC - Open Orphan PLC: 'Rapidly scaling up and building out higher value, longer term contracts'

Health Open Orphan PLC: 'Rapidly scaling up and building out higher...

on 14/5/20

Health Innovenn split will ‘maximise shareholder value’, says Venn CEO

on 5/10/16

Health New contract build global footprint, says Venn Life Sciences...

on 3/8/16

Editor's picks

WA Kaolin Ltd - WA Kaolin set to list on ASX on Thursday 26 November after successful $22 million IPO

Mining

WA Kaolin to list on ASX tomorrow after reeling in $22 million in...

2 hours, 3 minutes ago

Greenland Minerals Ltd - Greenland Minerals raises $30 million in strongly supported international institutional placement

Mining

Greenland Minerals raises $30 million in strongly supported...

2 hours, 37 minutes ago

Emyria Ltd - Emyria launches drug development program focused on mental health based on real-world evidence analysis

Health

Emyria launches drug development program focused on mental health...

3 hours, 6 minutes ago

Chalice Gold Mines Ltd - Chalice Gold Mines successes set ‘very strong platform’ to continue growing

Mining

Chalice Gold Mines successes set ‘very strong platform’ to...

3 hours, 15 minutes ago

Brookside Energy Ltd - Brookside Energy continues to lower formation fluid level in the SWISH AOI and generate cash flowing rates

Energy

Brookside Energy's successful Mitchell well workover provides...

4 hours, 12 minutes ago

ATCO - Australian Vanadium signs MoU with ATCO Australia for green hydrogen supply for its processing plant

Mining

Australian Vanadium signs MoU with ATCO Australia to supply green...

6 hours, 5 minutes ago

Linius Technologies Ltd launches new product WHIZZARD in the video conferencing and enterprise collaboration markets

Tech

Linius Technologies launches new product WHIZZARD in video...

6 hours, 41 minutes ago

Kingston Resources Ltd - Kingston Resources takes first step to becoming significant low-cost, mid-tier gold producer with positive PFS for Misima Gold Project

Mining

Kingston Resources takes big step to becoming low-cost, mid-tier...

23 hours, 3 minutes ago

Blackstone Minerals Ltd - Blackstone Minerals generates new nickel-copper-PGE target at King Snake prospect

Mining

Blackstone Minerals geophysics team strikes again with large new...

1 day, 3 hours ago

Cobalt Blue Holdings Ltd - Cobalt Blue to source ethical cobalt from an emerging Australian mine

Mining

Cobalt Blue to source ethical cobalt from an emerging Australian mine

1 day, 4 hours ago

RNS

Open Orphan PLC - Directors Change

21 hours, 42 minutes ago

Open Orphan PLC - Collaboration with HIC-VAC and Wellcome Trust

5 days, 21 hours ago

Open Orphan PLC - Price Monitoring Extension

3 weeks, 5 days ago

Open Orphan PLC - Exercise of Share Options

3 weeks, 5 days ago

Open Orphan PLC - New 2-year contract with a tier 1 German company

3 weeks, 5 days ago

Open Orphan PLC - Statement re further media comment

on 16/10/20

Open Orphan PLC - Interim Results for 6 months ended 30 June 2020

on 30/9/20

Open Orphan PLC - New £4.3m Challenge Study Contract Win

on 28/9/20

2 min read

Prev article

Health Open Orphan PLC targeting Q3 for profitability as it expands range of pharma and COVID-19 services

2 min read

Next article

Health Open Orphan first half: 'period of integration, restructuring and setting the scene' for future growth

2 min read